These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Ann Neurol; 1987 Dec; 22(6):753-61. PubMed ID: 2893583 [Abstract] [Full Text] [Related]
8. Management and outcome of severe Guillain-Barré syndrome. Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM, Miller DH. QJM; 1995 Apr; 88(4):243-50. PubMed ID: 7796073 [Abstract] [Full Text] [Related]
9. Plasma exchange and selective adsorption in Guillain-Barré syndrome--a comparison of therapies by clinical course and side effects. Rosenow F, Haupt WF, Grieb P, Jiménez-Klingberg C, Borberg H. Transfus Sci; 1993 Jan; 14(1):13-5. PubMed ID: 10148310 [Abstract] [Full Text] [Related]
11. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Lancet; 1997 Jan 25; 349(9047):225-30. PubMed ID: 9014908 [Abstract] [Full Text] [Related]
12. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. van der Meché FG, Schmitz PI. N Engl J Med; 1992 Apr 23; 326(17):1123-9. PubMed ID: 1552913 [Abstract] [Full Text] [Related]
13. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome. Fasanaro AM, Pizza V, Stella L. Acta Neurol (Napoli); 1992 Apr 23; 14(4-6):369-80. PubMed ID: 1293980 [Abstract] [Full Text] [Related]
14. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Ann Neurol; 1997 Mar 23; 41(3):298-306. PubMed ID: 9066350 [Abstract] [Full Text] [Related]
15. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin]. Imai N, Miyata K, Terayama Y, Ishihara N. Rinsho Shinkeigaku; 1997 Jun 23; 37(6):520-2. PubMed ID: 9366182 [Abstract] [Full Text] [Related]
16. [Chronic polyneuritis of the Guillain-Barré type. Significance of long-term electroneurographic follow-up findings]. Haupt WF, Gibbels E, Hann P. Nervenarzt; 1988 May 23; 59(5):274-7. PubMed ID: 2841615 [Abstract] [Full Text] [Related]
17. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis]. Fasanaro AM, Pizza V, Florio C, Tancredi G, Fabbri P, Aiello L, Viscidi E, Rossi V, Vacca C. Riv Neurol; 1991 May 23; 61(1):39-45. PubMed ID: 1857922 [Abstract] [Full Text] [Related]
18. [Treatment of Guillain-Barré syndrome by plasma exchange: proposal of a therapeutic strategy]. Raphael JC, Chevret S, Jars-Guincestre MC, Chastang C, Gajdos P. Rev Neurol (Paris); 1996 May 23; 152(5):359-64. PubMed ID: 8881430 [Abstract] [Full Text] [Related]
19. Immunotherapy for Guillain-Barré syndrome in the US hospitals. Alshekhlee A, Hussain Z, Sultan B, Katirji B. J Clin Neuromuscul Dis; 2008 Sep 23; 10(1):4-10. PubMed ID: 18772694 [Abstract] [Full Text] [Related]
20. An approach to the care of patients with Guillain-Barré syndrome. Griswold K, Guanci MM, Ropper AH. Heart Lung; 1984 Jan 23; 13(1):66-72. PubMed ID: 6559188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]